Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy

343Citations
Citations of this article
117Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We measured interleukin-1 beta (IL-1β) and tumour necrosis factor-alpha (TNF-α) in the vitreous humour and serum of patients with proliferative diabetic retinopathy (PDR), in order to determine the role of these cytokines in the pathogenesis of the disease. Vitreous and serum samples were collected from 21 patients with PDR who were undergoing pars plana vitrectomy. Control vitreous samples were obtained from cadavers and control serum samples from healthy subjects. The cytokines were measured by enzyme-linked immunosorbent assay. Vitreous IL-1β and TNF-α concentrations in patients with PDR exceeded those of controls (P<0.05), as did serum IL-1β and TNF-α. We suggest that increased vitreous IL-1β and TNF-α levels may play a significant role in the pathogenesis of PDR, which features abnormal cell proliferation and neovascularisation.

Cite

CITATION STYLE

APA

Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006). Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye, 20(12), 1366–1369. https://doi.org/10.1038/sj.eye.6702138

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free